Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
European Clinical Respiratory Journal|September 18, 2020
Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizerKhalid Abd-Elaziz, Hanneke Oude Elberink, Zuzana DiamantCurrent Opinion in Pulmonary Medicine|October 16, 2020
Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseasesKhalid Abd-Elaziz, Milos Jesenak, Martina Vasakova, et al.Current Opinion in Pulmonary Medicine|October 16, 2020
Allergen bronchoprovocation test: an important research tool supporting precision medicineLouis-Philippe Boulet, Andréanne Côté, Khalid Abd-Elaziz, et al.Human Reproduction (Oxford, England)|June 8, 2017
A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trialsKhalid Abd-Elaziz, Ingrid Duijkers, Lars Stöckl, et al.Progress in Brain Research|February 27, 2021
Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa studyKlaus Kucher, Donald Johns, Frank Wagner, et al.Drug Development and Industrial Pharmacy|November 25, 2018
Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action)Joanne Wilkinson, Khalid Abd-Elaziz, Izaak den Daas, et al.Neurology and Therapy|July 2, 2022
Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human StudyValérie Bourdès, Peter Dogterom, André Aleman, et al.British Journal of Clinical Pharmacology|August 18, 2024
Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human studyLan Gao, Anuradha Bhattacharyya, Brian Beers, et al.European Journal of Clinical Pharmacology|December 22, 2025
New insights into the effects of dissolution profiles on the pharmacokinetics of trientine dihydrochlorideKarl Heinz Weiss, Carlot Kruse, Khalid Abd-Elaziz, et al.Clinical Drug Investigation|December 17, 2020
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy SubjectsKhalid Abd-Elaziz, Christine Voors-Pette, Kang-Ling Wang, et al.Pageof 2